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MYOCARDIAL 
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Ejection fraction is a major determinant of morbidity and mortality for 
patients with ischemic heart disease. Patients with an ejection fraction of 
0.40 or less are generally recognized as having a poorer prognosis than 
those patients with an ejection fraction of 0.50 or better and remain a 
heterogeneous group. It would be useful if patients with a favorable surgical 
prognosis could be identified preoperatively. Fifty-five patients who under- 
went coronary artery bypass grafting and had an ejection fraction less than 
0.40 (mean of 0.23 -- 0.07 standard deviation) were studied by catheter 
measurement of pulmonary arterial pressure and radionuclide left ven- 
triculography. Heart rate, systemic blood pressure, pulmonary artery 
pressures, cardiac output, and ejection fraction were measured, at rest, 
after nitroglycerin was given intravenously and with supine bicycle exercise. 
Forty-seven patients who had follow-up longer than 4 years were divided 
into two groups according to their life status (alive or dead) 4 years after 
operation. Measured variables of exercise stress tests and clinical charac- 
teristics were entered into factor analysis to obtain a cardiac function factor 
score for predicting the life status after 4 years. The cardiac function factor 
score was highly loaded by stroke index (rest, nitroglycerin), cardiac index 
(exercise), systemic vascular resistance index (exercise), and history of 
congestive heart failure. The cardiac function factor provided a predictive 
value superior to that of any individual variable. By dividing the patients 
into two groups by cardiac function factor score, the actuarial 5-year 
survival was 72% versus 17% for good and poor prognosis groups, 
respectively (p < 0.0001). Preoperative xercise stress testing data inte- 
grated by factor analysis provide a predictive tool for patients with a low 
ejection fraction. (J THORAC CARDIOVASC SURG 1995;110:944-51) 
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rience 2, 3 and the experience of others demonstrate 
a substantial survival advantage for patients who 
undergo surgical revascularization compared with 
patients treated medically. 4-n Nonetheless, patients 
with poor ventricular function do not, as a group, do 
as well as patients with a normal ejection fraction 
(EF) who undergo revascularization, s-13 Since 1968 
our group has undertaken myocardial revasculariza- 
tion for patients with poor ventricular function. The 
hospital mortality rate since 1973 is 7%. In 1984 we 
reported our experience in patients with an EF of 
0.20 or less) We found that 5-year survival was 
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influenced by the presence of congestive heart fail- 
ure (CHF):  the 5-year survival was 24% for patients 
with CHF  at the time of operation, 40% for patients 
successfully treated for CHF  before operation, and 
60% for those patients who had never had CHF. 
Besides the presence or absence of heart failure, it 
would be of great use if we could identify other 
significant predictors of  survival in these patients 
with high-risk conditions. 
A number of  methods have been proposed to 
predict the prognosis after myocardial revasculariza- 
tion for patients with ischemic heart disease. 4" 6. 9. 14 
However, no study, to the best of  our knowledge, 
has been undertaken relating preoperative xercise 
testing combined with radionuclide ventriculogra- 
phy and catheterization of the right side of the heart 
to prognosis in a cohort of Patients with poor 
ventricular function who then undergo myocardial 
revascularization. To improve predictability, several 
variables were integrated by the use of  a factor 
analysis technique to calculate a factor score, which 
we shall call the cardiac function factor (CFF). The 
usefulness of this CFF score was tested in terms of 
long-term actuarial survival. 
Methods 
From February 11, 1980, through June 6, 1987, a total 
of 6166 coronary artery bypass operations were done at 
our institution. Twenty-four percent (1455) of the patients 
had a left ventricular EF less than 0.40. Of those patients 
who were primarily referred to one surgeon (P.Z.), 73 
patients underwent exercise stress testing as part of the 
preoperative evaluation. The mean EF in these patients 
was 0.23 -+ 0.07 standard eviation by cineventriculogra- 
phy. There were 61 men and 12 women whose ages ranged 
from 37 to 79 years (mean 60 -+ 9 years). All patients 
enrolled in the test were believed to be questionable 
candidates for operation as judged by the surgeon. After 
informed consent was obtained, the patient underwent 
catheterization of the right side of the heart and gated 
radionuclide left ventriculography. 
Of those 73 patients who underwent exercise testing, 17 
patients (14 men and 3 women) were excluded from 
surgical treatment. Three patients did not have operable 
disease and six patients refused operation. Five patients 
had pulmonary hypertension that was not reduced by 
nitroglycerin infusion. In three patients, the EF was 
significantly decreased by nitroglycerin injection or by 
exercise. At the time, we thought that these results 
obtained from the nitroglycerin challenge and exercise 
stress test were contraindications to operation, although 
we no longer believe this is necessarily the case. The 
average age of the medically treated patients was 62 --- 6 
years and the New York Heart Association (NYHA) 
functional class was 3.31 _+ 0.61. The mean EF deter- 
mined by cineangiography was 0.22 +-- 0.08. The actuarial 
5-year survival of medically treated patients was 19%. 
Fifty-six patients underwent operation. One patient 
who also required left ventricular aneurysmectomy was 
eliminated from the study group. The remaining 55 pa- 
tients (mean age 60 _+ 10 years, 46 men, 9 women) 
underwent myocardial revascularization. 
Measurements. With the patient placed in the supine 
position, electrocardiographic leads were placed to monitor 
lead II activity. A pulmonary artery pressure line capable of 
measuring cardiac output was inserted via an internal jugular 
vein and the radial artery was cannulated. Heart rate; 
systolic, diastolic, and mean arterial pressure; systolic and 
diastolic pulmonary artery pressure; pulmonary artery wedge 
pressure; and cardiac output were determined. Cardiac 
output was normalized by body surface area to give a cardiac 
index (CI). Gated radionuclide blood pool imaging studies 
were acquired in the left anterior oblique position and EF 
was measured. From these measurements, troke index 
(SI = 1000 X Clhaeart rate), left ventricular end-diastolic 
volume index (EDVI = SI/EF), left ventricular end-systolic 
volume index (ESVI = EDVI - SI), and total systemic 
vascular esistance index (TSVRI = 80 × mean arterial 
pressure/CI) were calculated. 
Protocols. Three sets of measurements were obtained. 
First, the control measurement was done with the patient in 
the supine position. Next, measurements were made after 
nitroglycerin (0.2 to 0,4 mg) was given intravenously to 
produce a reduction in systolic blood pressure of 10 to 20 
mm Hg. After the systolic pressure returned to control levels, 
supine bicycle xercise was initiated. Hemodynamic variables 
were measured at the peak level of exercise. Exercise was 
discontinued if there were any ischemic electrocardiographic 
changes or if the patient reported exhaustion or angina. No 
measurement of peak work was made. 
Before the test, the patient was given an intravenous 
injection of cold pyrophosphate (15 mg). After 30 min- 
utes, 25 mCi of technetium 99m pertechnetate was in- 
jected. Gated blood pool imaging studies were done in the 
left anterior oblique position. 
Surgical technique. The operative technique used has 
been described previously by Zubiate, Kay, and Mendez. z In 
brief, before cardiopulmonary b pass was begun, the proxi- 
mal anastomoses were done by excluding a portion of the 
ascending aorta. The heart-lung machine was filled with 
lactated Ringer's olution. After completion of the proximal 
anastomoses, cardiopulmonary b pass was instituted and the 
patient was cooled to a core temperature of 25 ° to 28 ° C. 
Potassium cardiac arrest was accomplished and the distal 
anastomoses completed. The left ventricle was not vented. A
left atrial pressure line was usually inserted via the right 
superior pulmonary vein. Care was taken to avoid ventricular 
distention. Isoproterenol or epinephrine was used judi- 
ciously for a cardiotonic effect. Nitroprusside was used as 
needed for afterload reduction. The intraaortic balloon assist 
device was used if adequate pressure was not maintained 
after cardiopulmonary b pass. 
Statistics. Four-year survival after operatio n was taken 
to be the end point. Of the 55 patients considered, 47 had 
such a complete 4-year history. These 47 patients were 
divided into two groups: nonsurvivors, which includes 17 
patients who died within the 4-year period, and survivors, 
which includes 30 who survived beyond 4 years. For each 
hemodynamic variable, differences between groups were 
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Table I. Clinical, catheterization, and operative 
characteristics of patients who underwent coronary 
artery bypass grafting 
No. % 
NYHA functional class 
1I 4 7 
III 30 55 
IV" 21 38 
CHF 
No history of CHF 17 31 
Compensated CHF 31 56 
Symptomatic CHF 7 13 
Angina 
No chest pain 18 33 
Stable 25 45 
Unstable 12 22 
EF by cineangiogram 
0.10-0.19 15 27 
0.20-0.29 29 53 
0.30-0.39 11 20 
No. of bypass grafts 
One 2 4 
Two 16  29 
Three 27 49 
Four 9 16 
Five 1 2 
examined by means of t tests. For attribute clinical vari- 
ables, ~ or Fisher's exact tests were done. After the 
aforementioned univariate screening of variables associ- 
ated with outcome was done, we performed a factor 
analysis on those hemodynamic variables ignificant at 
p = 0.10 or less. In this way, the variables were screened 
to see which appeared individually to discriminate be- 
tween the two groups. To enter attribute variables into 
factor analysis, arbitrary scores were given, such as sex 
(1 = men, 2 = women), angina (0 = none, 1 = stable, 2 
= unstable), and CHF (0 = no history, 1 = positive 
history but compensated, 2 = uncontrolled and symptom- 
atic). 
Factor analysis is a technique used to create a new 
variable, which in this case we call the CFF, that concep- 
tually averages correlated variables. With factor analysis, 
we can create principal components that provide an 
adequate summary of the data or a set of variables being 
considered 15(see Appendix A). A CFF was computed for 
each patient. A t test was done to see whether the CFF 
could discriminate between the groups. In addition, the 
relation between the CFF and the survival was determined 
by logistic analysis (see Appendix B). 
Means and standard eviations were computed for all 
the continuous variables. Actuarial survival analysis was 
done by the Kaplan-Meier method. The difference be- 
tween the cumulative survival between the two groups was 
determined by the Cox-Mantel test. 
Results 
General information is summarized in Table I. 
Mean NYHA functional class was 3.3 _+ 0.6. Thirty- 
Table II. Comparison of clinical variables between 
those who did not survwe for 4 years (nonsurvivors) 
and those who did survive 4 years (survivors) 
Nonsurvivors Survivors 
Clinical variables (n = 17) (n = 30) p Value 
Age (yr) 61.6 +_ 9.5 59.9 _+ 10.4 0.579 
BSA (m 2) 1.78 _+ 0.19 1.87 _+ 0.21 0.142 
Female (%) 23.5 6.7 0.170" 
Angina (%) 64.7 66.7 0.892* 
CHF (%) 0.009* 
Compensated 64.7 53.3 
Symptomatic 29.4 6.7 
NYHA 0.202* 
functional class (%) 
II 5.9 10.0 
III 41.2 63.3 
1V 52.9 26.7 
Values given as mean plus or minus the standard eviation where 
appropriate. BSA, Body surface area. 
*Derived by the g 2 test or Fisher's exact est. 
eight patients (69%) had either compensated or 
symptomatic CHF. Eighteen patients (33%) had no 
angina. The average EF determined by cineangiog- 
raphy was 0.23 _+ 0.07. Most of the patients (94%) 
received from two to four bypass grafts (mean 2.8 + 
0.8). No patient had a myocardial infarction within 
30 days before the operation. 
Tables II and I I I  show the summary of all the 
clinical and hemodynamic variables for the patients 
who did not survive for 4 years (nonsurvivors) and 
those who were alive after 4 years (survivors). They 
also show the probability level for the significance of 
the difference between the groups for that variable. 
There were 12 hemodynamic and clinical variables 
that showed a significance level for differences on 
the order of 0.10 or less. Quite significant was the 
history of CHF (p = 0.009) and stroke index after 
nitroglycerin injection (p = 0.007). The nonsurvivor 
group had a higher NYHA functional class and 
more women. The nonsurvivor group also showed a 
higher heart rate (rest, nitroglycerin) and a higher 
pulmonary artery pressure in systole (nitroglycerin) 
and diastole (nitroglycerin, exercise). CI during ex- 
ercise and after nitroglycerin injection was larger in 
the survivor group. During exercise, total systemic 
vascular esistance index was lower in the survivor 
group. Although ejection fraction after nitroglycerin 
injection was lower in the nonsurvivor group, the 
difference did not reach significance (p = 0,10). 
Presence of angina was not, by itself, predictive. In 
addition to the aforementioned 12variables, NYHA 
functional class and patient gender were entered 
into factor analysis, because their distributions be- 
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Table IlL Comparison of hemodynamic variables between those who did not survive for 4 years 
(nonsurvivors) and those who did survive 4 years (survivors) 
Nonsurvivors Survivors 
Hemodynamic variables N Mean +_ SD N Mean +_ SD p Value 
Rest 
HR (beats/min) 17 82.8 ___ 17.4 30 75.7 _+ 9.7 0.079 
SBP (mm Hg) 17 144 ± 31 30 144 - 32 1.000 
DBP (mm Hg) 17 66 ~ 12 30 64 -4- 12 0.618 
MAP (mm Hg) 17 92 +__ 17 30 91 +_ 17 0.813 
EF 17 0.20 ± 0.08 30 0.23 -+ 0.08 0.192 
CI (L/min • m 2) 17 2.70 ± 0.65 30 3.03 -+ 0.80 0.165 
PAPS (mm Hg) 17 38.1 ± 20.9 30 33.8 _+ 15.3 0.431 
PAPD (mm Hg) 17 15.8 ± 10.6 30 13.9 -+ 7.8 0.481 
PAW (mrn Hg) 17 18.2 ± 10.5 25 16.2 _+ 11.6 0.608 
SI (ml/m 2) 17 34.0 ± 11.3 30 40.4 ± 10.8 0.064 
EDVI (ml/m 2) 17 188 ± 77 30 195 -+ 68 0.759 
ESVI (ml/m 2) 17 154 _ 72 30 155 _+ 65 0.980 
TSVRI (dynes. sec- m2/crn 5) 17 2848 _+ 748 30 2553 -+ 794 0.218 
Nitroglycerin 
HR (beats/rain) 17 88.9 ± 16.5 30 81.1 +- 12.8 0.076 
SBP (ram Hg) 17 106 ~ 30 30 117 +_ 32 0.217 
DBP (mm Hg) 17 52 Z 10 30 56 _+ 13 0.333 
MAP (mm Hg) 17 74 ± 20 30 76 -+ 18 0.705 
EF 17 0.21 ± 0.08 30 0.25 _+ 0.08 0.101 
CI (L/min • m 2) 17 2.43 ± 0.62 30 2.99 -+ 0.95 0.036 
PAPS (rnm Hg) 16 28.3 +__ 17.2 30 19.1 +_ 8.9 0.021 
PAPD (mm Hg) 16 11.9 ± 8.8 30 8.0 -+ 5.6 0.078 
PAW (mm Hg) 10 10.0 ± 7.2 30 7.5 --- 5.4 0.295 
SI (ml/m 2) 17 27.6 ± 9.4 30 37.4 _+ 12.4 0.007 
EDVI (ml/m z) 17 148 ± 59 30 165 ± 81 0.459 
ESVI (ml/m ~-) 17 120 + 55 30 127 -+ 75 0.741 
TSVRI (dynes. sec. m2/cm s) 17 2579 _ 1024 30 2219 _+ 823 0.195 
Exercise 
HR (beats/min) 17 98 _ 19 29 106 - 18 0.146 
SBP (mm Hg) 17 173 _+ 33 29 183 _+ 39 0.378 
DBP (mm Hg)" 17 72 +_ 14 29 72 -+ 16 0.931 
MAP (mm Hg) 17 105 ___ 19 29 109 +- 24 0.626 
EF 16 0.21 +_ 0.08 29 0.23 +_ 0.10 0.453 
CI (L/min. rn z) 16 3.32 __. 1.30 29 4.22 - 1.65 0.068 
PAPS (mrn Hg) 17 55.9 ___ 23.0 29 60.2 ± !8,2 0.484 
PAPD (mm Hg) 17 22.6 -4- 11.2 29 28.8 -+ 11.5 0.081 
PAW (mm Hg) 9 33.7 _ 20.4 21 40.6 -+ 14.3 0.297 
SI (ml/m z) 16 34.0 _+ 13.8 29 39.3 -+ 14.2 0.236 
EDV1 (ml/m z) 15 201 -4- 87 29 200 _+ 74 0.979 
ESVI (ml/m 2) 15 164 ± 86 29 159 -+ 70 0.844 
TSVRI (dynes. sec. m2/cm 5) 16 2944 -4- 1226 29 2288 _+ 768 0.032 
SD, Standard eviation; HR, heart rate; SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial pressure; CI, cardiac 
systolic pulmonary artery pressure; PAPD, diastolic pulmonary artery pressure; PAW, pulmonary artery wedge pressure; SI, stroke index; EDVI, 
volume index; ESVI, end-systolic volume index; TSVR1, total systemic vascular esistance index. 
index; PAPS, 
end-diastolic 
tween survivors and nonsurvivors were quite differ- 
ent (p = 0.20 and 0.17, respectively) and because 
these variables are known risk factors, which can be 
obtained easily. 
The component loading values, which resulted 
from the factor analysis of the 14 variables, indicate 
the relation of each variable to CFF. Most highly 
loaded (in absolute value larger than 0.6) were 
stroke index at rest (-0.860), CI at exercise 
(-0.800), stroke index after nitroglycerin i fusion 
(-0.788), total systemic vascular resistance index at 
exercise (0.718), cardiac index after nitroglycerin 
infusion (-0.698), and history of CHF (0.663). CFF 
accounted for 35.9% of the total variance. The 
factor was constructed tohave a mean of zero and a 
standard eviation of one. In our sample, the value 
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Fig. 1. Comparison of probability of survival after operation between patients whose CFF was greater 
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Fig. 2. Comparison of probability of survival after operation between patients with exercise CI (CI Ex) 
greater than 3.5 L/min • m 2 and those with values less than 3.5 L/min • m 2. 
of the CFF ranged from -2.88 to 2.67 (see Appen- 
dix n). 
The CFF was significantly different between the 
two groups: -0.366 ___ 0.826 in the survivor group 
versus 0.616 + 1.142 in the nonsurvivor group (p = 
0.0045). It had greater discriminant ability in pre- 
dicting 4-year survival than any individual variable. 
We determined a CFF of 0.45 as a cutoff point to 
yield the highest X 2 value; 82.4% of the patients with 
a CFF less than 0.45 survived after 4 years, whereas 
15.4% of those with a CFF higher than 0.45 died 
within 4 years (X 2 = 18.3, p < 0.001). The discrimi- 
nant ability of CFF was also tested in terms of 
actuarial ife-table analysis with a follow-up period 
up to 7 years. All 55 patients were divided into two 
groups by CFF of 0.45. The two curves were differ- 
ent with a p value of less than 0.0001 (Fig. 1). 
When the patients were divided by exercise CI of 
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alive when the CFF was greater than 0.45. Regression analysis was done for patients' values plotted above 
to fit logistic model; probability (alive beyond 4 years) = 1/(1 + exp[-B0 - B1 x CFF]). Best fit was 
obtained when parameters B0 and B1 were set to B0 = 0.6764 and B1 = -1.1853. 
3.5 L/min • m 2 the two actuarial survival curves were 
different (Fig. 2). Significant differences in survivor- 
ship were also observed when other variables were 
used: history of heart failure (7-year survival rate of 
92% + 7% with negative history versus 31% __ 10% 
with positive history, p = 0.0025), stroke index after 
nitroglycerin i fusion (7-year survival rate of 54% _+ 
12% for stroke index >25 ml versus 28% + 14% for 
stroke index -<25 ml, p = 0.048). However, none of 
the individual variables had a discriminant ability 
equal to or better than that of the CFF. The relation 
between the CFF and the distribution of the survi- 
vors and nonsurvivors i shown in Fig. 3. 
There were three hospital deaths in the series 
(5.5% hospital mortality). The values for CFF were 
0.591, 2.158, and 2.555 in these patients. The exer- 
cise CI was less than 3.0 L/min e in all these patients 
and two of the patients had symptomatic CHF. 
Discussion 
Our group has undertaken myocardial revascular- 
ization for patients with poor ventricular function 
for more than 20 years. We know from experience 
that some patients with low EF do extremely well, 
whereas others do not benefit from operation. In 
patients with poor ventricular function, EF is an 
incomplete and inadequate predictor of outcome. 
Postextrasystolic potentiation certainly implies via- 
bility of the myocardium. 4 A history of CHF is a 
particularly ominous sign. 3 The presence of angina 
is reassuring, but how bad a sign is the absence of 
angina? 
Although individual clinical and hemodynamic 
factors may exhibit predictive ability, a combination 
of relevant clinical characteristics and hemodynamic 
variables by factor analysis produces a superior 
predictor, the CFF. Our findings have practical 
implication. Proper selection of candidates for re- 
vascularization from this population of patients can, 
at times, be as much an art as a science. 
The patients ubjected to study by our protocol 
were all patients to whom the surgeons "felt uncom- 
fortable" about offering surgical treatment. Patients 
not treated surgically had a 5-year survivorship of 
19%. The 5-year survival of patients in our series 
with a CFF greater than 0.45 was 17%. This does not 
differ from the survival reported in the literature for 
patients treated medically. 16 It may not be reason- 
able to proceed with surgical therapy in such a 
patient. 
For those patients with CHF at the time of 
evaluation for revascularization, a prohibitive CFF 
would provide the basis for delaying operation to 
allow for adequate medical treatment. If the heart 
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failure can be controlled, one might expect enough 
improvement in the CFF to warrant operation at 
that time. Further, for those patients with a favor- 
able CFF, it is encouraging to the patient, cardiol- 
ogist, and surgeon to know that, despite poor ven- 
tricular function, greater than 70% 5-year survival 
can be expected. This is important information to be 
able to convey to the patient and cardiologist when 
therapeutic options are being discussed. 
In our series, CI during exercise was a significant 
predictor of the outcome. Franciosa 17 and Fuster is 
and their colleagues showed CI at rest was a predic- 
tor of survivorship in patients with heart failure 
caused by either coronary artery disease or idio- 
pathic dilated cardiomyopathy. Observations have 
previously been limited to medically treated pa- 
tients. To the best of our knowledge, no data have 
been available in the surgical iterature that relate 
survival with preoperative CI, either at rest or 
during exercise, in patients with normal or de- 
pressed ventricular function. Further study is re- 
quired to confirm our positive correlation between 
exercise CI and surgical survival. 
The predictive ability of EF at rest was negligible. 
In the three protocols, only EF after nitroglycerin 
injection helped distinguish between the survivors 
and nonsurvivors (Table III). It is noteworthy also 
that there was no change in EF with exercise. 
Although the response of EF to exercise may be 
useful in predicting prognosis in some settings, it 
seems applicable only to patients with better ven- 
tricular function. 19' 20 The poor predictive ability of 
EF at rest is consistent with recent findings that 
showed a lack of correlation between EF and 
CHF21.22 or exercise capacity. 23' 24 The interpreta- 
tion of EF is difficult, because EF is afterload 
dependent, 25 and both contractility and vascular 
resistance may vary during exercise. In addition, 
diastolic function has been recognized as the cause 
for some forms of heart failure. 22 Our preliminary 
study shows that diastolic function is impaired in 
patients who had a poor response in CI to exercise. 26 
Further study is warranted to reveal the complicated 
relations among exercise, contractility, diastolic 
function, vascular esistance, and EF. 
It would benefit he patients if we could obtain the 
CFF noninvasively. Of those 14 variables used to 
calculate CFF, those most highly loaded were related 
to cardiac output. Because cardiac output is closely 
related to oxygen consumption, 27 oxygen consumption 
during exercise may be used as a substitute for cardiac 
output. Indeed, it has been reported that oxygen 
consumption atthe peak level of exercise is related to 
the survival of patients with heart failure. 24 Pulmonary 
artery pressure and EF can be estimated by echocar- 
diography. Thus there is the possibility of reconstruct- 
ing the CFF score noninvasively. 
This study is retrospective. It suffers from the 
usual problems associated with retrospective stud- 
ies. For the predictability of CFF score to be tested 
strictly, a prospective study should be done. The 
peak exercise level obtained for each patient was not 
noted. We can thus make no recommendations as to 
the minimum level of exercise needed to test the 
patient "fairly." This point may be moot, however, 
inasmuch as these patients have severely compro- 
mised conditions and can only "do their best." 
Despite these limitations, we believe our method of 
predicting long-term survival for patients with isch- 
emic heart disease with poor ventricular function is 
utilitarian and has benefit in the practical process of 
identifying which patient with a high-risk condition 
will benefit from surgical revascularization. 
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Appendixes 
Appendix A. Factor analysis is a method of creating 
principal components hat provide an adequate summary 
of the data or a set of variables being considered. When 
factor analysis is done, multiple factors are created. 
Because there were 14 variables in this study, 14 factors 
were created. Each factor is a linear equation of the 14 
variables. In some cases, more than one factor may be 
necessary to adequately describe the dependence and 
independence among the set of variables being consid- 
ered. One method to screen the factors is to calculate 
"eigenvalue." In our study, there were four factors that 
showed eigenvalue greater than one. The first factor, 
which we called CFF, showed highest eigenvalue of 5.017. 
The eigenvalues of the remaining three factors were 2.703, 
1.252, and 1.170. CFF explained 35.9% of the standard 
variance, whereas the percentages xplained by the re- 
maining factors were 19.3%, 8.9%, and 8.4%, respectively. 
We therefore used only the first factor, CFF, which turned 
out to be a simple and effective way to predict long-term 
survival. 
Appendix B. The relation between CFF and 4-year 
survival was estimated by means of the logistic model; 
probability (alive beyond 4years) = 1/(1 + exp[-B0 - B1 
× CFF]), where B0 and B1 are the coefficients obtained 
from regression analysis. Shown in Fig. 3 is the relation- 
ship between CFF and the estimated 4-year survival as 
expressed by the logistic model with the coefficients of B0 
= 0.6764 and B1 = -1.1853. For example, there is an 
86.5% probability of survival to 4 years after operations 
for this type of patient with a CFF = -1.0. There is a 
37.5% probability of survival to 4 years after operations 
for this type of patient with a CFF = 1.0. 
